Crotonaldehyde (CRA) anticorps (HRP)
-
- Antigène
- Crotonaldehyde (CRA)
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- HRP
-
Application
- Western Blotting (WB), ELISA
- Specificité
- Specific for Crotonaldehyde modified proteins. Does not cross-react with Acrolein, Hexanoyl Lysine, 4-Hydroxy-2-hexenal, 4-Hydroxy nonenal, Malondialdehyde, or Methylglyoxal modified proteins.
- Purification
- Protein G Purified
- Immunogène
- Crotonaldehyde modified Keyhole Limpet Hemocyanin (KLH)
- Clone
- 2A8-1
- Isotype
- IgG1
-
-
- Indications d'application
-
- WB (1:1000)
- ELISA (1:1000)
- optimal dilutions for assays should be determined by the user.
- Commentaires
-
A 1:1000 dilution of ABIN5650478 was sufficient for detection of Crotonaldehyde-modified proteins in 1 μg of Crotonaldehyde-BSA conjugate by ECL immunoblot analysis using goat anti-mouse IgG:HRP as the secondary antibody.
- Restrictions
- For Research Use only
-
- Concentration
- 1 mg/mL
- Buffer
- PBS pH 7.4, 50 % glycerol, 0.09 % Sodium azide, Storage buffer may change when conjugated
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C
- Stockage commentaire
- Conjugated antibodies should be stored at 4°C
-
- Antigène
- Crotonaldehyde (CRA)
- Autre désignation
- Crotonaldehyde
- Classe de substances
- Chemical
- Sujet
- Lipid peroxidation occurs when oxidizing agents attack carbon-carbon double bonds found in unsaturated lipids. In addition to membrane degradation, oxidation end-products have been found to damage cell viability through their mutagenic and toxic properties. These downstream functional consequences facilitate the development of disease and premature aging. Crotonaldehyde (CRA) is a carcinogenic, conjugated aldehyde produced endogenously via lipid peroxidation. It covalently modifies biomolecules, forming adducts with DNA and nucleophilic amino acid residues of proteins such as lysine (1).
-